Investigating Genetic Status in Patients Presenting to Clinic

Launched by LONDON HEALTH SCIENCES CENTRE RESEARCH INSTITUTE OR LAWSON RESEARCH INSTITUTE OF ST. JOSEPH'S · Jun 12, 2023

Keywords

ClinConnect Summary

This clinical trial is studying the genetic factors that may contribute to different types of dementia, including Frontotemporal Dementia, Alzheimer's Disease, and Lewy Body Dementia. Researchers are interested in understanding how specific genes might influence the risk of developing these conditions, especially in patients who have a family history of dementia. By analyzing blood samples from participants, the trial aims to identify genetic changes that could be linked to these neurodegenerative diseases.

To participate in the study, you need to be at least 18 years old and either have a diagnosed neurodegenerative disorder yourself or be a family member of someone with such a diagnosis. If you decide to join, you'll be asked to provide a blood sample, which will help researchers learn more about the genetic aspects of these diseases. Your participation could contribute to valuable insights that may improve the understanding and treatment of dementia in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Persons presenting to the cognitive clinic with a neurodegenerative disorder (for example, AD, FTD, LBD, ALSP, and related conditions);
• • Biological family members of someone diagnosed with a neurodegenerative disorder, presenting to clinic;
• • Age 18+ years old;
• • Consenting to a blood draw.
• Exclusion Criteria:
• • • Persons declining / unwilling / not able to have a blood draw.